We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

This study has been terminated.
(Contract ended)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01261299
First Posted: December 16, 2010
Last Update Posted: September 14, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Lawrence Livermore National Laboratory
National Institutes of Health (NIH)
Information provided by (Responsible Party):
University of California, Davis
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)